Jul 25, 2024, 00:18
Breaking Science in Gastrointestinal Cancers with Kohei Shitara – ESMO
ESMO (European Society for Medical Oncology) shared on LinkedIn:
“For ESMO members: Breaking Science in Gastrointestinal Cancers:
Kohei Shitara talks about the Perioperative pembrolizumab plus chemotherapy in locally-advanced gastric/GEJ cancer.
Don’t miss this video and others from the series on OncologyPRO.”
Source: ESMO/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 09:22
Dec 21, 2024, 09:06
Dec 21, 2024, 09:00
Dec 21, 2024, 08:51
Dec 21, 2024, 08:48
Dec 21, 2024, 08:42
Dec 21, 2024, 08:37
Dec 21, 2024, 08:29
Dec 21, 2024, 08:12